2015 ACVIM Forum Research Abstract Program

Ten cats recently diagnosed with diabetes mellitus that had not received any insulin therapy were recruited into the study (Group 1). Ten diabetic cats being treated with ProZinc R for at least 2 months that were clinically stable according to their owners were also recruited (Group 2). Inclusion criteria consisted of a diagnosis of diabetes mellitus, availability of complete medical records, and current rabies vaccination. Exclusion criteria included presence of ketosis, hyperosmolarity, concurrent disease, non-neutered status, steroid injection within the past 30 days, and current steroid treatment. A complete history, physical examination, CBC, chemistry profile, urinalysis, urine culture, T 4 , and fructosamine were obtained on each cat. Sensors for the Minimed Guardian R system were equilibrated and calibrated on each cat. Group 1 cats were started on ProZinc R at 0.5 U/kg bid with a meal-fed low carbohydrate diet. Group 2 cats were given Pro-Zinc R and fed according to their existing regime. Glucose curves were obtained over 72 hours with readings every 5 minutes.